Andrew Witty
CIK 1711304 · CEO, UHG · last filed 2025-03-20
Andrew Witty is a CEO, UHG who has filed 65 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing, for UNH, was dated Mar 20, 2025. Across all open-market trades the lifetime net is −$13.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $45.0M across reported positions. 65 SEC filings were submitted jointly with UNITEDHEALTH GROUP INC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
UNH price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
9900 BREN ROAD EAST, MN008-T502
MINNETONKA, MN 55343
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| UNH | CEO, UHG | 112,162 | $401.43 | $45.03M | -$13.52M | 60 | 2025-03-20 |
| G1 Therapeutics, Inc. (GTHX) Delisted | Director | — | $7.15 | — | $0 | 3 | 2019-06-14 |
Recent Filings
65 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-03-20 | UNH | Grant (A) | +114 | $0 | EDGAR |
| 2025-02-24 | UNH | Mixed | +15,828 | -$5.52M | EDGAR |
| 2025-02-18 | UNH | Tax (F) | −1,066 | -$558.4K | EDGAR |
| 2024-12-19 | UNH | Grant (A) | +114 | $0 | EDGAR |
| 2024-09-26 | UNH | Grant (A) | +95 | $0 | EDGAR |
| 2024-06-27 | UNH | Grant (A) | +110 | $0 | EDGAR |
| 2024-03-21 | UNH | Grant (A) | +99 | $0 | EDGAR |
| 2024-02-26 | UNH | Tax (F) | −2,554 | -$1.35M | EDGAR |
| 2024-02-23 | UNH | Mixed | +23,103 | -$5.60M | EDGAR |
| 2024-02-15 | UNH | Tax (F) | −2,151 | -$1.11M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.